(Q42649656)

4 November 2017

title

Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy (English)

1 reference

4 November 2017

Barentsen R

1

1 reference

4 November 2017

van de Weijer PH

series ordinal

2

1 reference

4 November 2017

Schram JH

series ordinal

3

1 reference

4 November 2017

publication date

1 January 1997

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

4 November 2017

published in

1 reference

4 November 2017

volume

71

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

73-80

1 reference

The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

Release of 17-beta-oestradiol from a vaginal ring in postmenopausal women: pharmacokinetic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

Evaluation of the urethral mucosa before and after oestrogen treatment in postmenopausal women with a new sampling technique

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

Effects of vaginally-administered oestriol on post-menopausal urogenital disorders: a cytohormonal study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

Factors influencing vaginal cytology, pH and bacterial flora in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

The vaginal epithelium in the postmenopause--cytology, histology and pH as methods of assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2896%2902612-7

7 January 2021

10.1016/S0301-2115(96)02612-7

Identifiers

DOI

1 reference

4 November 2017

1 reference